Asthma Management Handbook
Close window

Table. Add-on treatment options for acute asthma

Agent

Recommended use in acute asthma

Administration and dosage

Notes

Inhaled ipratropium bromide

Second-line bronchodilator if inadequate response to salbutamol

Via pMDI 21 mcg/actuation every 20 minutes for first hour

Repeat every 4–6 hours for 24 hours

 

 

Adults and children 6 years and over:
8 puffs

Children 0–5 years:
4 puffs

Use spacer (plus mask, if patient cannot use mouthpiece)

Via nebuliser every 20 minutes for first hour

Repeat every 4–6 hours

Adults and children 6 years and over:
500 mcg nebule

Children 0–5 years:
250 mcg nebule

If salbutamol is delivered by nebuliser, add to nebuliser solution

IV magnesium sulfate

Second-line bronchodilator in severe or life-threatening acute asthma, or when poor response to repeated maximal doses of other bronchodilators

IV infusion over 20 minutes

Adults: 10 mmol

Children 2 years and over: 0.1–0.2 mmol/kg (maximum 10 mmol)

Avoid magnesium sulfate in children younger than 2 years

Dilute in compatible solution

IV salbutamol

(only in ICU)

Third-line bronchodilator in life-threatening acute asthma that has not responded to continuous nebulised salbutamol after considering other add-on treatment options

Follow hospital/organisation’s protocol 

 

 

Use only in critical care units (e.g. emergency department, intensive care unit/high-dependency unit)

Monitor blood electrolytes, heart rate and acid/base balance (blood lactate)

Reduce initial dose for older adults. Consider dose reduction for those with impaired renal function. Impaired liver function may result in accumulation of unmetabolised salbutamol

Non-invasive positive pressure ventilation 

Consider if starting to tire or signs of respiratory failure

 

Do not sedate patient

If no improvement, intubate and start mechanical ventilation

Back to top 

Asset ID: 61